Patients with FA related to defects of BRCA2/FANCD1 exhibit a variety of cancers, including T-cell leukemia, acute myeloid leukemia, medulloblastoma, Wilms and other embryonal-type tumors3,24,38. Here, BRCA2 is linked to medulloblastoma.